baber/WOPTO huggingface dataset:
Patent DE-69423877-D1 (DE)
Inventor: CHOPPING GEOFFREY
IPC: H04J3/00
Filed: 1994-01-26
Granted: 2000-05-11
Abstract: PCT No. PCT/GB94/00152 Sec. 371 Date Dec. 8, 1995 Sec. 102(e) Date Dec. 8, 1995 PCT Filed Jan. 26, 1994 PCT Pub. No. WO94/17614 PCT Pub. Date Aug. 4, 1994A telecommunication switch protection arrangement has information sent in the form of an information frame through a switch. The information in the frame is reorganized in the switch between input and output and checked for parity by using a V4 byte in the frame before being sent from the switch.
Patent DE-69424291-D1 (DE)
Inventor: CARTER JOHN DAVID
IPC: H01M8/0217
Filed: 1994-08-12
Granted: 2000-06-08
Abstract: PCT No. PCT/DK94/00304 Sec. 371 Date Feb. 20, 1996 Sec. 102(e) Date Feb. 20, 1996 PCT Filed Aug. 12, 1994 PCT Pub. No. WO95/05685 PCT Pub. Date Feb. 23, 1995Vanadium doping has been found to increase the sinterability of LaxCayCrO3 (x+y=1) while retaining its high temperature electrical and chemical properties. Specimens of LaxCayCrO3 with about 2 mol % V were sintered at 1,300 DEG  to 1,450 DEG  C. for 2 to 8 hours to achieve more than 92% theoretical density, as compared to less than 75% for those specimens not containing V. The electrical conductivity of La0,76Ca0,26 CrO3+2 mol % V in 10-16 and 1 atm of O2, was measured to be 12 and 30 S/cm, respectively. Preliminary experiments with tape cast laminates and spray coated specimens give indication that LaxCayCrO3+V can be sintered on YSZ with good adherence between the two materials.
Patent DE-69432462-D1 (DE)
Inventor: TIGHE PATRICK J
IPC: A61K31/78
Filed: 1994-06-23
Granted: 2003-05-15
Abstract: A cyanoacrylate adhesive is applied onto surface skin areas prone to ulceration so as to inhibit formation of surface skin ulcers.
Patent DE-69434651-D1 (DE)
Inventor: CELESTE J
IPC: A61P1/02
Filed: 1994-12-06
Granted: 2006-05-04
Abstract: Compositions of proteins with tendon/ligament-like tissue inducing activity are disclosed. The compositions are useful in the treatment of tendinitis and tendon or ligament defects and in related tissue repair.
Patent DE-69513179-D1 (DE)
Inventor: CHU MIKE SSU-HAI
IPC: C04B35/468
Filed: 1995-12-18
Granted: 1999-12-09
Abstract: A sinterable dielectric ceramic powder composition comprising 95 to 98 parts by weight of a major ingredient consisting of 97.0 to 99.5 mole % barium titanate, 0.5 to 3.0 mole% magnesium oxide or a precursor therefor and 0 to 2.0 mole% manganese oxide or a precursor therefor and 0 to 0.2 mole% cobalt oxide or a precursor therefor; 2 to 5 parts by weight of a minor ingredient consisting of a ternary mixture of 15 to 30 mole% barium oxide or a precursor therefor, 15 to 30 mole% silicon dioxide or a precursor therefor and 40 to 70 mole% calcium titanate, which composition can be fabricated into multilayer ceramic capacitors with nickel, nickel alloy, palladium or palladium/silver alloy inner electrodes, the so formed capacitors having a variation of capacitance with temperature of less than +/- 20% over the range -55 DEG C to 140 DEG C as compared to the value at 25 DEG C and not containing any second phases after sintering.
Patent DE-69526279-D1 (DE)
Inventor: KIEHL OLIVER
IPC: G11C29/00
Filed: 1995-01-30
Granted: 2002-05-16
Abstract: A semiconductor memory device is disclosed which includes an input terminal for receiving, and an output terminal for producing a data word, each having a predetermined number of bits. An internal memory array stores a plurality of error correcting encoded codewords each encoding more than one data word. An error correcting encoder is coupled between the input terminal and the memory array for generating an error correcting encoded codeword, encoding the received data word, and storing the codeword in the internal memory array. An error correcting decoder is coupled between the internal memory array and the output terminal to retrieve an error correction encoded codeword from the internal memory array, correct any detected errors, and produce one of the more than one data words encoded in the retrieved codeword at the output terminal. <IMAGE>
Patent DE-69527854-D1 (DE)
Inventor: NAKAYAMA TOYOO
IPC: C07D295/28
Filed: 1995-12-27
Granted: 2002-09-26
Abstract: The present invention provide novel substituted amidinonaphthyl ester compounds effective for treatment of thrombosis. The present invention relates to compounds represented by the following formula (I) and pharmaceutically acceptable acid addition salts thereof: <CHEM> (wherein R1 and R2 are as defined in the specification).v
Patent DE-69529877-D1 (DE)
Inventor: PATITSAS GEORGE PHILEMON
IPC: C08L23/18
Filed: 1995-09-21
Granted: 2003-04-17
Abstract: Disclosed are expandable bladders for use in curing presses for hydrocarbon rubbers such as pneumatic tires. The bladders are a crosslinked elastomer comprising isobutylene repeat units and the bladder composition includes fluorinated ethylene polymers in particulate form dispersed throughout the bladder. A preferred isobutylene elastomer is a brominated copolymer of from 80 to 99 weight percent isobutylene and from 1 to 20 weight percent p-methylstyrene. The bladders have enhanced lubricity, reduced adhesion to cured tire innerliners, better resistance to cracking during flexing, and have lower tension set. The above enhancements allow hydrocarbon rubbers such as tires to be molded with fewer defects caused by abraded or deformed bladders. They also enhance the useful life of the bladder reducing the cost of tire curing.
Patent DE-69533540-D1 (DE)
Inventor: SUTTON R
IPC: H04B1/7077
Filed: 1995-07-10
Granted: 2004-10-28
Abstract: A novel an improved method of acquisition in a spread spectrum communication system is presented. In the present invention, a large window of PN chip offset hypotheses are searched and if an energy signal is found that might indicate the presence of the pilot signal having one of the chip offsets of the large search window, then a search of a subset of offset hypotheses, or small window, is searched.
Patent DE-69534368-D1 (DE)
Inventor: DERRA HANS
IPC: H05B41/24
Filed: 1995-05-22
Granted: 2005-09-15
Abstract: A circuit arrangement for operating a high pressure discharge lamp includes input terminals for connection to a supply voltage source and an apparatus coupled to the input terminals for supplying an alternating lamp current to the high pressure discharge lamp. A device (III) is provided for generating a current pulse in each half period of the lamp current. This current pulse has the same polarity as the lamp current and is superimposed on the lamp current in the latter part of a predetermined fraction of the half periods of the lamp current. The circuit substantially suppresses flickering of the discharge arc during lamp operation.
Patent DE-69534856-D1 (DE)
Inventor: NACAMULLI LAURETTE
IPC: G01N33/532
Filed: 1995-12-04
Granted: 2006-05-04
Abstract: The rate of a biomolecular reaction, such as an enzymatic reaction or an affinity binding reaction, is measured using electrochemiluminescence ("ECL"). The reaction is conducted in an electrochemical cell with a mixture of reagents including a luminophore which will relate the concentration of a reactant, a reaction partner or the reaction product of a reaction partner to the ECL intensity. The reaction partner is a reagent which reacts with the reactant and which participates with the luminophore (or its reaction product participates with the luminophore) to cause the emission of ECL. The ECL intensity is modulated with a series of electrical pulses which are applied to the mixture of reagents at a preselected potential and for preselected intervals of time and duration. The ECL intensity is measured at the same intervals to provide a timed series of values (P). The same experiment is repeated except that the modulation is conducted after the reaction has gone to completion to obtain a timed series of values (C). The same experiment is repeated a third time in the absence of the reaction partner to obtain a times series of values (B). The results are normalized (N) using the following formula: <maths id="MATH-US-00001" num="1"> <MATH OVERFLOW="SCROLL"> <MTABLE> <MTR> <MTD> <MROW> <MI>N</MI> <MO>=</MO> <MFRAC> <MROW> <MI>P</MI> <MO>-</MO> <MI>B</MI> </MROW> <MROW> <MI>C</MI> <MO>-</MO> <MI>B</MI> </MROW> </MFRAC> </MROW> </MTD> <MTD> <MROW> <MO>(</MO> <MI>I</MI> <MO>)</MO> </MROW> </MTD> </MTR> </MTABLE> </MATH> </MATHS> to obtain a series of values N which can be used to plot the time course (concentration vs. time) of the reaction.
Patent DE-69535961-D1 (DE)
Inventor: ABRIGNANI SERGIO
IPC: A61K35/12
Filed: 1995-08-17
Granted: 2009-07-16
Abstract: A method for antigen independent activation of T cells comprising contacting T cells with a combination of cytokines such as two or more of interleukin-2, interleukin-6 and tumor necrosis factor α.
Patent DE-69603205-D1 (DE)
Inventor: MANTHE ALEXANDRE
IPC: G06K7/00
Filed: 1996-12-10
Granted: 1999-08-12
Abstract: The invention relates to a portable chip card reader (1). This reader is designed so that it can operate even when it is stored. For this purpose it comprises, on one of its faces, an attachment means (4) to enable it to be fixed to the wall of a card holder compartment whilst leaving the card insertion slot (3) free. This attachment system allows simple handling of the reader under all circumstances. The chip card can be inserted either perpendicular or parallel to the direction in which information is displayed on a display device of the reader (1).
Patent DE-69614553-D1 (DE)
Inventor: MAKOVEC FRANCESCO
IPC: A61P25/00
Filed: 1996-06-28
Granted: 2001-09-20
Abstract: PCT No. PCT/EP96/02829 Sec. 371 Date Dec. 29, 1997 Sec. 102(e) Date Dec. 29, 1997 PCT Filed Jun. 28, 1996 PCT Pub. No. WO97/02248 PCT Pub. Date Jan. 23, 1997A compound represented by the general formula (I) shown below or a pharmaceutically acceptable salt thereof can be used as the active ingredient in a pharmaceutical preparation. The pharmaceutical preparation is desirable for its anti-ulcer activity, for therapeutic use against tumors sustained by gastrin and other bioactive polypeptides correlated therewith, for therapeutic use in treating disorders of the gastrointestinal tract, for the treatment of pathological conditions of the central nervous system linked to imbalances in the neural physiological levels of gastrin or other bioactive polypeptides correlated therewith, for use in the treatment and prevention of pathological eye conditions caused by surgical treatment of cataracts or chronic ocular inflammation, and for the prevention of diseases of other sensory organs.
Patent DE-69614971-D1 (DE)
Inventor: HARRIS PAUL J
IPC: C09D5/44
Filed: 1996-11-12
Granted: 2001-10-11
Abstract: Cathodic electrocoat compositions containing self-crosslinking polymers are described. The polymers of the invention are formed from an epoxide-functional prepolymer having polyepoxide and extender segments. Each extender segment has at least one pendant hydroxyalkyl carbamate group. The prepolymer is reacted with an amine compound having at least one blocked primary amine group and at least one epoxide-reactive group. The primary amine group is unblocked and the resultant polymer is dispersed in water with the aid of a neutralizing acid.
Patent DE-69621558-D1 (DE)
Inventor: GOGLIO LUIGI
IPC: B65B45/00
Filed: 1996-10-17
Granted: 2002-07-11
Abstract: A system is described for handling flat, hollow bodies, particularly frames destined to feed automatic packaging machines, according to which use is foreseen of hollow tubular cores (2) on which the frames (1) are inserted and retained by liftable tongues (10). The tubular cores (2) complete with frames (1) or loaders/magazines (25) are stored in rows placed one on top of the other inside container boxes (20), and can be used to load a feed unit (30) of a packaging machine, comprising a plurality of hollow columns (A,B,C,D), each forming an inner housing (31), accessible through a corresponding door (32) at the front, for stacking of the frames (1). <IMAGE>
Patent DE-69624283-D1 (DE)
Inventor: KORENIC BRANISLAV
IPC: B01J19/00
Filed: 1996-04-22
Granted: 2002-11-21
Abstract: A heat exchange apparatus (10) which can be used as an evaporative condenser, fluid cooler or wet-air cooler, is provided with a direct evaporative heat exchange section (90) overlying an indirect evaporative heat exchange section (50). An air entry zone (120) common to both heat exchange sections (50;90) receives an air stream blown into this zone by at least one fan (24), thereby pressurizing the plenum such that the air stream is forced to split and enter each section (50;90) while inside the apparatus. This eliminates the need for separate air entries, thus condensing the size and cost of the apparatus, while increasing heat exchange capacity. A countercurrent air flow pattern through the direct section (90) provides a uniformly cooled evaporative liquid for use in the indirect section (50). The evaporative liquid flow is parallel to the air stream provided in the indirect section. A process fluid inside the circuits of the indirect section (50) can accept or reject heat from the evaporative liquid received from the direct section (90), with a part of the heat being transferred into the indirect section air stream in sensible and latent form, thus increasing or decreasing the enthalpy of the air stream. The remaining heat can be either stored or released from the evaporative liquid to increase or decrease its temperature. The evaporative liquid is collected in a sump (30) and then pumped upwardly for re-distribution across the direct evaporative heat exchange section (90). <IMAGE>
Patent DE-69635806-D1 (DE)
Inventor: FARCASIU DAN
IPC: C07F9/6512
Filed: 1996-06-06
Granted: 2006-04-20
Abstract: Novel chemotherapeutic agents having utility in treating infectious diseases such as periodontal disease, certain urinary tract infections, and infectious urinary tract stones, are obtained by combining chemically a diphosphonate compound with a therapeutic agent effective against the foregoing diseases.
Patent DE-69702765-D1 (DE)
Inventor: DEMERTZIS IOANNIS
IPC: C23F1/46
Filed: 1997-05-07
Granted: 2000-09-14
Abstract: Stainless steel pickling process in which a pickling solution containing HF and Fe3+ ions as essential components is used, and wherein the oxidation to Fe3+ of the Fe2+ formed during the process in order to maintain the Fe3+ concentration to the predetermined value, is electrolytically carried out by submitting the pickling solution as it is to an oxidation process in an electrolytic cell equipped with anode made of inalterable materials chosen among graphite, granular coal, lead and with cathodes made of stainless steel, graphite or other unalterable materials, said cell working with an applied tension between 1 and 8 V and with an anodic current density between 0.4 and 15 A/dm2.
Patent DE-69704296-D1 (DE)
Inventor: GILLET JEAN-PHILIPPE
IPC: C07C69/63
Filed: 1997-05-21
Granted: 2001-04-26
Abstract: Preparation of an alkyl halodifluoroacetate of formula CF2X-C(O)-OR (I) involves (i) contacting a 1,1-difluoro-tetrahaloethane of formula CF2X-CY2-Z (II) with an alcohol R-OH (III) at a molar ratio (III)/(II) of not more than 30 (preferably 5 - 20) in the presence of O2 and a small quantity (p) of a chemical free radical initiator (IV); (ii) heating the mixture to at least 40 degrees C (preferably 60-80 degrees C) ; (iii) introducing a major quantity (q) of (IV), continuously or by successive additions whilst maintaining temperature as in (ii) and in the presence of O2, such that the molar ratio (p+q)/(II) is 0.01-0.2 (preferably 0.05 - 0.1) ; (iv) cooling the reaction mixture to ambient temperature, removing the crude product by distillation and distillating in the presence of an aliphatic, cycloaliphatic or aromatic solvent ; and (v) recovering (I). X = F, Cl, Br or I ; R = 1-10C aliphatic hydrocarbyl; Y,Z = Br, Cl or I.
Patent DE-69705643-D1 (DE)
Inventor: LAMBIASE ALESSANDRO
IPC: C12N5/02
Filed: 1997-11-21
Granted: 2001-08-16
Abstract: The nerve growth factor (NGF) is used for the storage of corneas in culture, for the production and the storage in vitro of single cell populations of the corneal morphological and functional unit (i.e. epithelium, stroma/keratocytes and endothelium) and of the conjunctival epithelium, and for the production and the storage of corneal and conjunctival tissues, in particular for transplantation purposes. The NGF is also proposed for use in the therapy and/or the prophylaxis of diseases of the corneal surface, wherein a lack of integrity of the corneal and conjunctival morphological and functional unit occurs, in particular for pathologies having a dystrophic or neurodystrophic basis, both congenital and acquired.
Patent DE-69727319-D1 (DE)
Inventor: AALTONEN PASI
IPC: F22B1/18
Filed: 1997-10-23
Granted: 2004-02-26
Abstract: PCT No. PCT/FI97/00640 Sec. 371 Date Jun. 18, 1999 Sec. 102(e) Date Jun. 18, 1999 PCT Filed Oct. 23, 1997 PCT Pub. No. WO98/17948 PCT Pub. Date Apr. 30, 1998A self-regulating exhaust gas boiler intended for the recovery of thermal energy from the exhaust gases of diesel engines or the like, has a steam/water cylinder acting as the water and steam space. There is a convection part acting as the vaporizer and being fitted in the vertical orientation between the steam/water cylinder and a lower cylinder, or the like, and connected to it. There is at least one downcomer interconnecting the steam/water cylinder and the lower cylinder, or the like. At least one valve or corresponding device regulates the amount of water and the water level in the convection part is mounted between the steam/water cylinder and the lower cylinder, or the like, preferably in the lower section of the downcomer. The preferably vertically disposed pipes of the convection part are partly filled with water, the power of the exhaust gas boiler being regulated by adjusting the water level in the convection part by means of a valve on the basis of the different heat transfer properties of water, a water-steam mixture, and steam. The valve can be continuously regulated and/or of the open/shut type. The pipe or pipes connecting the convection part to the steam/water cylinder can penetrate the mantle of the steam/water cylinder at a point above the highest permitted steam/water cylinder water level.
Patent DE-69729591-D1 (DE)
Inventor: SIGONI RICCARDO
IPC: A21C11/04
Filed: 1997-11-12
Granted: 2004-07-22
Abstract: A device for shaping portions of bread dough or the like comprises a roller (25) having opposed side handles (26), a substantially central body (27), a plurality of discs (29) projecting from the central body (27) and extending around its periphery, and shaping elements (28) projecting from the central body (27). The device has the advantage of simplifying and speeding up operations to shape portions of bread dough and, at the same time, producing loaves which can easily be divided into separate bread rolls having a certain regularity of shape. <IMAGE>
Patent DE-69732370-D1 (DE)
Inventor: WOULFE R
IPC: A61K49/06
Filed: 1997-11-12
Granted: 2005-03-03
Abstract: The present invention provides compositions comprising contrast agents capable of binding non-covalently to blood proteins. The compositions of the invention provide increased residence time of contrast agents in the vasculature, thus providing effective blood pool contrast agents. The invention also provides methods for imaging a patient comprising administering a composition of the invention to a patient and obtaining an image.
Patent DE-69733068-D1 (DE)
Inventor: CHENG HENRICH
IPC: A61F2/04
Filed: 1997-07-24
Granted: 2005-05-25
Abstract: A medical device (1) of a biocompatible material for use in the treatment of a gap or defect in the central nervous system, which device has a proximal end (5) and a distal end (6) comprising openings (7). The device is adapted to enable connection of nerve fibers of gray and white matter between the proximal end (5) and distal end (6) thereof in predetermined openings (7). The device is of a substantially cylindrical form, or a substantially flat or plate like form and is made of plastic. The openings (7) in at least one end (5, 6) bear distinctively different indicia thereby to indicate whether nerve fibers of gray matter or nerve fibers of white matter are to be inserted therein.
Patent DE-69736083-D1 (DE)
Inventor: WALDREP CLIFFORD J
IPC: A61K9/12
Filed: 1997-07-02
Granted: 2006-07-20
Abstract: The present invention provides a high dose pharmaceutical liposome aerosol composition comprising about 12-30 mg/ml of a pharmaceutical compound, and about 130-375 mg of a phospholipid/ml starting reservoir concentration. Specifically, the present invention is drawn to anti-inflammatory glucocorticoids, immunosuppressive compounds, anti-fungal compounds, antibiotic compounds, anti-viral compounds, and anti-cancer compounds delivered via a high dose liposome aerosol composition in a phospholipid. More specifically, the invention provides a high dose cyclosporin A liposome aerosol composition comprising up to about 30 mg/ml cyclosporin A in up to about 225 mg of a phospholipid/ml starting reservoir concentration. Also provided is a high dose budesonide-liposome aerosol composition comprising up to about 15 mg/ml budesonide in up to about 225 mg of a phospholipid/ml starting reservoir concentration.
Patent DE-69738380-D1 (DE)
Inventor: HOCH ROBERT
IPC: D01F11/16
Filed: 1997-09-04
Granted: 2008-01-24
Abstract: A method of treating carbon fibrils and carbon fibril structures such as assemblages, aggregates and hard porous structures with a plasma to effect an alteration of the surface or structure of the carbon fibril or fibrils. The method can be utilized to functionalize, prepare for functionalization or otherwise modify the fibril surface via a "dry" chemical process.
Patent DE-69738669-D1 (DE)
Inventor: SCARBOROUGH NELSON L
IPC: A61K35/32
Filed: 1997-09-15
Granted: 2008-06-19
Abstract: An osteogenic surgical implant for surgical implantation in the body comprising a radiopaque material and a radiolucent material including demineralized allograft bone particles, the radiopaque material and radiolucent material being uniformly distributed in an inert carrier, wherein the radiopaque material is provided in sufficient quantity for use as a marker.
Patent DE-69811154-D1 (DE)
Inventor: HELMY N
IPC: B07B1/46
Filed: 1998-06-17
Granted: 2003-03-13
Abstract: This improved screening apparatus for sorting various size aggregates utilizes a screen made of polyurethane having two sets of perpendicular evenly spaced parallel webs each of which enclose a wire provided for reinforcement. If desired, the reinforcing wires can be single or multiple through either one or through both sets of webs. Web segments extend between web intersections. Areas enclosed by opposed adjacent web segments provide for the screen openings. This area can contain either a single hole or a plurality of holes to provide a number of different screen sizes. The holes increase in cross-section from the screen aggregate input side to the output side to eliminate or greatly minimize particles wedging within the holes. Backing bucker bars of various widths attached to the lower side of the screen provide a predetermined screen cross-section when their lower edges are supported horizontally. Hooks attached to opposite sides of the screen by bolts, arranged to engage mating mounting brackets, permit applying varying tension to the screen by tightening nuts which secure the bolts. <IMAGE>